dog |
LDLo |
oral |
3gm/kg (3000mg/kg) |
? |
"Experimental Chemotherapy, Volume II," Schnitzer, R.J., and F. Hawking, eds. Academic Press New York, 1964Vol. 2, Pg. 249, 1964. |
mouse |
LD50 |
intraperitoneal |
2300mg/kg (2300mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Chemotherapy Vol. 21, Pg. 175, 1973. |
mouse |
LD50 |
intravenous |
1460mg/kg (1460mg/kg) |
? |
"Modern Pharmaceuticals of Japan, V," Tokyo, Japan Pharmaceutical, Medical and Dental Supply Exporters' Assoc., 1975Vol. -, Pg. 105, 1975. |
mouse |
LD50 |
oral |
2300mg/kg (2300mg/kg) |
? |
Chemotherapia. Vol. 8, Pg. 63, 1964. |
mouse |
LD50 |
subcutaneous |
> 5gm/kg (5000mg/kg) |
? |
Chemotherapy Vol. 21, Pg. 175, 1973. |
mouse |
LD50 |
unreported |
5gm/kg (5000mg/kg) |
? |
Chemotherapia. Vol. 6, Pg. 273, 1963. |
rat |
LD50 |
intraperitoneal |
2690mg/kg (2690mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Chemotherapy Vol. 21, Pg. 175, 1973. |
rat |
LD50 |
oral |
6200mg/kg (6200mg/kg) |
? |
Toxicology and Applied Pharmacology. Vol. 18, Pg. 185, 1971. |
rat |
LD50 |
subcutaneous |
> 5gm/kg (5000mg/kg) |
? |
Chemotherapy Vol. 21, Pg. 175, 1973. |
women |
TDLo |
oral |
160mg/kg/10D- (160mg/kg) |
ENDOCRINE: HYPOGLYCEMIA |
Archives of Internal Medicine. Vol. 143, Pg. 827, 1983. |